Volume 6, Issue 1 (6-2019)                   vacres 2019, 6(1): 29-32 | Back to browse issues page

‎ 10.29252/vacres.6.1.29

XML Print

The Current Status of Bacillus Calmette‐Guérin Vaccine Protective Efficacy
Patricia Méndez-Samperio *
Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional
Abstract:   (5128 Views)
The bacillus Calmette‐Guérin (BCG) vaccine against pulmonary tuberculosis (TB) remains with poor protective efficacy. However BCG is the only licensed vaccine against human TB. This review discusses the main research progress in the field of TB vaccine development and will summarize the current status, and main challenges for the development of a safer and more efficient TB vaccine.
Keywords: BCG, global health, clinical trials, tuberculosis, vaccine
Full-Text [PDF 374 kb]   (1331 Downloads)    
Type of Study: Review article | Subject: Vaccine development, efficacy and safety evaluation
Received: 2020/01/16
Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.